DR REDDYS LABORATORIES LTD — Regulatory Filings 2021

Oct 7, 2021

•·· Dr.Reddy's ��•

Dr. Raddy's Laboratories Ltd. 8-2-337, Road No. 3 , Banjara Hills, Hyderabad- 500 034, Telangana, India.

CIN: L85195TG1984PLC004507

Tel :+91 40 4900 2900 Fax :+91 40 4900 2999 Email :mail@drreddys.com www.drreddys.com

October 7, 2021

Corporate Relationship Department BSE Limited Dalal Street, Fort Mumbai - 400 001 Fax Nos.: 022-22723121 / 22723719 / 22722037 / 22722039

National Stock Exchange of India Ltd. "Exchange Plaza" Bandra-Kurla Complex, Bandra (East), Mumbai - 400 051 Fax Nos.: 022-26598120/ 26598237/ 26598238

Scrip Code: 500124

Scrip Code: DRREDDY-EQ

Dear Sir/ Madam,

Sub: Press Release

Please find enclosed a Press Release on "Dr. Reddy's to release Q2 FY 22 results on October 29th, 2021 Earnings call slated for October 29th @5:30 PM 1ST / 8:00 AM EDT."

This is for your information.

With regards,

==> picture [117 x 65] intentionally omitted <==

Encl: As above

• CC:- New York Stock Exchange Inc.(Stock Code :RDY) NSE IFSC Ltd

Press Release

Dr. Reddy's �;•

DR. REDDY'S LABORATORIES LTD.

8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500034, Telangana, India.

==> picture [230 x 32] intentionally omitted <==

AMIT AGARWAL USHA IYER amita@drreddys.com ushaiyer@drreddys.com

Dr. Reddy's to release Q2 FY 22 results on October 29[th] , 2021 Earnings call slated for October 29[th ] @ 5:30 PM 1ST / 8:00 AM EDT

Hyderabad, India, October 7[th] , 2021

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, "NSEIFSC: DRREDDY) will announce results for the quarter ended September 30[th] , 2021 on Friday, October 29[th] , 2021 after the Board Meeting.

Summary of Events

IEventDate and TimeiMedium -- ---	IEventDate and TimeiMedium -- ---	IEventDate and TimeiMedium -- ---
Release of financial resultsPress meet presentationEarnings CallPlayback of Earnings CallTranscript of the Earnings call	October 29th,after the Board MeetingWill be available on the Company'swebsiteOctober 29th,5:30 PM 1ST / 8:00 AMEDTAfter the earnings call till November4th,2021Will be available on the Company'swebsite	Stock Exchange, Media, Companywebsite, Business wire, EmailCompany's websitew.drredd�s.comHosted by the Company .(Details below)Details belowCompany's websitewww.drredd�s.com

Earnings Call

Following the release, the management of the Company will host an earnings call to discuss the Company's financial performance. (Dial In and other details given below)

Play Back

The play back will be available after the earnings call, till November 4[th] , 2021. For play back dial in phone No: +91 22 7194 5757 J +91 22666 3 5757, and Playback Code is 57312.

==> picture [82 x 83] intentionally omitted <==

Conference Joining Information

Option 1: E:xpi:ess Join wiil:h Diamond Pass[tM ]

Pre-register with the below link and join without waiting for the operator.

https:/ /serices .choruscall .in/Diarond PassReqistra tion/reqister?confiration Number= 7069312&Iin kSecu ritString=1 ac 796eb00

Optiol 2: Jetn through bel�w llal . lT Numbe,sUniversal Access Number:+91 22 6280 1219+91 227115 8120	Optiol 2: Jetn through bel�w llal . lT Numbe,sUniversal Access Number:+91 22 6280 1219+91 227115 8120
International Toll Free Number:	USA:1 866 746 2133UK:0 808 101 1573Singapore:800 101 2045Hong Kong:800 964 448

No password/pin number is necessary to dial in to any of the above numbers. The operator will provide instructions on asking questions before and during the call.

About Dr. Reddy's: Dr Reddy's Laboratories ltd (BSE: 500124, NSE: DRREDDY, NYSE: ROY NSEIFSC: DRREDDY) is an integrated pharmaceutical company. committed to providing affordable and innovative medicines for healthier lives Through its three businesses - Pharmaceutical Ser1ices & Active Ingredients. Global Generics and Proprietary Products - Dr Reddy's offers a portfolio of products and services including APls, custom pharmaceutical services. generics, biosimilars and differentiated fcrmulaticns. Our major therapeutic areas of focus are gastrointestinal, cardiovascular diabetology. oncology, pain management and dermatolcgy Dr Reddy's operates in markets across the globe Our Major markeis include - USA. India, Russia & CIS countries, and Europe. For more information, log on to: w.drreddy.com

Disclaimer: This press release may include statements of future expectations and other forNard-looking statements that are based on the management's current views and assumptions and involve known or unknown risks and uncertainties that could cause actual results. performance or events to differ materially from those expressed or implied in such statements. In addition to statements which are forNard-looking by reason of context, the words "may", "will", "should", "expects", "plans", "intends", "anticipates", "believes", "estimates". "predicts", "potential", or "continue" and similar expressions identify forNard-looking statements Actual results, performance or events may differ materially from those in such statements due to without limitation, (i) general economic conditions such as performance of financial markets, credit defaults, currency exchange rates , interest rates , persistency levels and frequency / severity of insured loss events (ii) mortality and morbidity levels and trends, (iii) changing levels of competition and general competitive factors, (iv) changes in laws and regulations and in the policies of central banks and/or governments. (v) the impact of acquisitions or reorganization , including related integration issues, and (vi) the susceptibility of our industry and the markets addressed by our, and our customers' products and services to economic downturns as a result of natural disasters, epidemics, pandemics or other widespread illness, including coronavirus (or C0/IO-19), and ('1ii) other risks and uncertainties identified in our public filings with the Securities and Exchange Commission, including those listed under the "Risk Factors" 2nd "FcrNarc-Lccking Statements" secticns cf our Annual Repcrt on Ferm 20-F fer the year ended M2rch 31 2021 The company assumes nc obligation lo L!pdate an1· information ccntaIned herein

==> picture [250 x 8] intentionally omitted <==

==> picture [82 x 84] intentionally omitted <==